Literature DB >> 20069073

Chronic fungal sinusitis leading to disastrous cerebral aspergillosis: a case report.

Muhammad J Popalzai1, Anurag Kushawaha, Neville Mobarakai, Rohail Asrar, Farida Durrani.   

Abstract

Cerebral angioinvasion is a fatal complication of disseminated aspergillosis and has been rarely described in diabetic population in the absence of ketoacidosis. We present a case of invasive fungal sinusitis in a 79 year old diabetic man who presented with chronic frontal headaches. Despite appropriate medical and surgical treatment, the disease progressed and the patient eventually succumbed to a fatal ruptured mycotic aneurysm. We emphasize that clinicians should consider this in the differential diagnoses of all diabetics who present with chronic sinusitis, as early diagnosis could be the key in the successful treatment.

Entities:  

Year:  2009        PMID: 20069073      PMCID: PMC2805656          DOI: 10.1186/1757-1626-2-9406

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  12 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Disseminated aspergillosis involving the brain: distribution and imaging characteristics.

Authors:  D R DeLone; R A Goldstein; G Petermann; M S Salamat; J M Miles; S J Knechtle; W D Brown
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

3.  Angioinvasive cerebral aspergillosis presenting as acute ischaemic stroke in a patient with diabetes mellitus.

Authors:  M I Norlinah; H A Ngow; B B Hamidon
Journal:  Singapore Med J       Date:  2007-01       Impact factor: 1.858

4.  Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

Authors:  Martine Florent; Sandrine Katsahian; Anne Vekhoff; Vincent Levy; Bernard Rio; Jean-Pierre Marie; Anne Bouvet; Muriel Cornet
Journal:  J Infect Dis       Date:  2006-01-30       Impact factor: 5.226

5.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 6.  Aspergilloma of the brain: an overview.

Authors:  T Nadkarni; A Goel
Journal:  J Postgrad Med       Date:  2005       Impact factor: 1.476

7.  Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.

Authors:  Enrico Orciuolo; Marta Stanzani; Martina Canestraro; Sara Galimberti; Giovanni Carulli; Russell Lewis; Mario Petrini; Krishna V Komanduri
Journal:  J Leukoc Biol       Date:  2007-07-11       Impact factor: 4.962

Review 8.  MR of cerebral aspergillosis in patients who have had bone marrow transplantation.

Authors:  Y Miaux; P Ribaud; M Williams; A Guermazi; E Gluckman; C Brocheriou; M Laval-Jeantet
Journal:  AJNR Am J Neuroradiol       Date:  1995-03       Impact factor: 3.825

9.  Intracerebral aspergillus abscess: case report.

Authors:  H J Klein; H P Richter; W Schachenmayr
Journal:  Neurosurgery       Date:  1983-09       Impact factor: 4.654

10.  Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.

Authors:  T J Walsh; D B Hier; L R Caplan
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.